Deerfield Management’s Five Prime Therapeutics FPRX Stock Holding History
Bought
Maintained
Sold
Other funds holding FPRX
Deerfield Management's FPRX Position: Q1 2018 in Review
Deerfield Management sold out of Five Prime Therapeutics (FPRX) in Q1 2018, closing a stake of 450,728 shares — an estimated $9.9M sold.
Deerfield Management first reported a position in FPRX in Q4 2015 and held it in 7 quarters. The position peaked at $28.2M in Q4 2015. 128 funds tracked by Wall St. Rank hold FPRX as of Q1 2018.
- Deerfield Management reported no remaining Five Prime Therapeutics position as of Q1 2018 after selling out during the quarter.
- Deerfield Management sold 450,728 Five Prime Therapeutics shares in Q1 2018, an estimated $9.9M.
- Deerfield Management first reported a position in Five Prime Therapeutics in Q4 2015 and held it in 7 quarters.
- Deerfield Management's Five Prime Therapeutics position peaked at $28.2M in Q4 2015.
- 128 funds tracked by Wall St. Rank held Five Prime Therapeutics as of Q1 2018.
Based on Deerfield Management's 13F filing for Q1 2018, filed 15 May 2018.